Assisted Living Locators, a leading nationwide senior placement and referral service, is going purple for the fourth annual year this June in support of Alzheimer's & Brain Awareness Month. The ...

On Monday, H.C. Wainwright analyst Emily Bodnar increased the price target for Purple Biotech Ltd. (NASDAQ: PPBT) shares to $34 from the previous $33 while maintaining a Buy rating.Currently ...

REHOVOT, Israel, May 12, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that ...

Pre-clinical research collaboration with Icahn School of Medicine at Mount Sinai for CAPTN-3 tri-specific antibody platform Purple Biotech entered into a Research Collaboration Agreement with the ...

REHOVOT, Israel - Purple Biotech Ltd. (NASDAQ/TASE: PPBT), a clinical-stage biopharmaceutical company with a market capitalization of $6.07 million, today announced the appointment of Shai Lankry ...

His extensive experience in the U.S. and European biotech and pharma markets, coupled with his passion for guiding companies towards financial success, make him a great match for Purple Biotech as we ...

including leading a U.S. IPO and M&A transaction “I’m excited to join Purple Biotech at such a pivotal time,” said Mr. Lankry. “The Company’s innovative science and commitment to ...

On Monday, H.C. Wainwright analyst Emily Bodnar increased the price target for Purple Biotech Ltd. (NASDAQ: PPBT) shares to $34 from the previous $33 while maintaining a Buy rating.Currently trading ...

Pre-clinical research collaboration with Icahn School of Medicine at Mount Sinai for CAPTN-3 tri-specific antibody platform Purple Biotech entered into a Research Collaboration Agreement with the ...

(RTTNews) - Purple Biotech Ltd. (PPBT, PPBT.TA), an Israeli clinical-stage biotechnology company, on Monday announced that it has appointed Shai Lankry as its Chief Financial Officer. Lankry has ...

Emily Bodnar, an analyst at H.C. Wainwright, raised her price target for Purple Biotech Ltd. (NASDAQ:PPBT) from $33 to $34 ...